Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: Randomized analysis approach

Statistics in Medicine

Volumn 21, Issue 5, 2002, Pages 675-687

  Matsuyama, Yutaka ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Causal model; Compliance; Counterfactual; Randomized clinical trial; Repeated binary outcome

Indexed keywords

ANTINEOPLASTIC AGENT; COLONY STIMULATING FACTOR 1; PLACEBO;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CALCULATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEBRILE NEUTROPENIA; HUMAN; HYPOTHESIS; INFORMATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS; VALIDATION PROCESS;

DRUG THERAPY; HUMANS; LEUKEMIA, MYELOID; MACROPHAGE COLONY-STIMULATING FACTOR; MODELS, BIOLOGICAL; NEUTROPENIA; RANDOMIZED CONTROLLED TRIALS; TREATMENT REFUSAL;

EID: 0037088329     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1002     Document Type: Article

References (29)

1. Compliance as an explanatory variable in clinical trials (with discussion)
2. On estimating efficacy from clinical trials
3. A method for the analysis of randomized trials with compliance information: An application to the Multiple Risk Factor Intervention Trial
4. Identification of causal effects using instrumental variables
5. Correcting for non-compliance in randomized trials: An application to the ATBC study
6. Confounding and collapsibility in causal inference
7. Clinical efficacy trials with categorical data
8. The central role of the propensity score in observational studies for causal effects
9. Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model
10. Correcting for non-compliance in randomized trials using rank preserving structural failure time models
11. Randomized intent-to-treat analyses
12. A method for the analysis of repeated binary outcomes in randomized clinical trials with noncompliance
13. Human urinary macrophage colony-stimulating factors reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid double-blind controlled study
14. Confidence intervals for causal parameters
15. Bayesian inference for causal effects: The role of randomization
16. Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure
17. Adjusting for non-compliance and contamination in randomized clinical trials
18. Statistical Principles for Clinical Trials (ICH E9); an introductory note on an international guideline
19. Inference and missing data
20. Missing data in longitudinal studies
21. Longitudinal data analysis using generalized linear models
22. Correcting for non-compliance in randomized trials using structural nested mean models
23. The analysis of randomized and non-randomized AIDS treatment trials using a new approach to causal inference in longitudinal studies
24. Bounds on treatment effects from studies with imperfect compliance
25. Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes
26. Comment on paper by J.D. Angrist, G.W. Imbens and D.R. Rubin
27. Analysis of semiparametric regression models for repeated outcomes in the presence of missing data
28. Estimating exposure effects by modelling the expectation of exposure conditional on confounders